Zim Laboratories Ltd dividend

The Dividend per Share of Zim Laboratories Ltd is ₹ 0 as of 2024 .a1#The Dividend Payout of Zim Laboratories Ltd changed from 5.09 % on March 2019 to 0 % on March 2024 . This represents a CAGR of -100.00% over 6 years. a1#The Latest Trading Price of Zim Laboratories Ltd is ₹ 114.35 as of 25 Jul 15:30 .a1#The Market Cap of Zim Laboratories Ltd changed from ₹ 201.82 crore on March 2019 to ₹ 465.33 crore on March 2024 . This represents a CAGR of 14.94% over 6 years. a1#The Revenue of Zim Laboratories Ltd changed from ₹ 94.64 crore to ₹ 119.4 crore over 8 quarters. This represents a CAGR of 12.32% a1#The EBITDA of Zim Laboratories Ltd changed from ₹ 13.08 crore to ₹ 17.18 crore over 8 quarters. This represents a CAGR of 14.61% a1#The Net Pr of Zim Laboratories Ltd changed from ₹ 5.15 crore to ₹ 8.09 crore over 8 quarters. This represents a CAGR of 25.33% a1#

Zim Laboratories Ltd was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in the State of Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Maharashtra, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector. During the year 2019-20, ZIM Health Technologies Limited was acquired thereby resulting as a wholly owned subsidiary of the company . SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia. In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/ Pharmerging Markets and EU.